Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
00:16:07 EDT Wed 30 Apr 2025
Enter Symbol
or Name
USA
CA



Q:APDN - APPLIED DNA SCIENCES INC - https://www.adnas.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
APDN - Q2.80.72·0.924.30.90+0.03844.5651.55101,0840.86  0.9195  0.858237.495  0.72319:49:21Apr 2115 min RT 2¢

Recent Trades - Last 10 of 1084
Time ETExPriceChangeVolume
19:49:21Q0.890.02841
19:46:59Q0.890.0284584
19:45:40Q0.900.03842,650
19:33:29Q0.900.03841
19:27:07Q0.900.03843
19:05:30Q0.890.028425
19:02:30Q0.890.028420
19:02:20Q0.89010.028510
19:01:41Q0.89010.02851
18:50:58Q0.90010.0385200

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-04-21 09:02U:APDNNews ReleaseApplied DNA's LineaRx Subsidiary Stands Ready to Support the Reshoring of Drug Development and Manufacturing with U.S.-Produced Synthetic DNA
2025-04-08 09:03U:APDNNews ReleaseApplied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement
2025-04-01 09:46U:APDNNews ReleaseApplied DNA Positions TR8 PGx Testing Service as Pre-Emptive Testing for Safety of Fluoropyrimidine-Based Cancer Therapeutics Following Publication of Food and Drug Administration Safety Announcement
2025-03-26 09:02U:APDNNews ReleaseApplied DNA Submits Validation Package to New York State Department of Health for H5 Bird Flu/Pan-Influenza A Laboratory-Developed Test
2025-03-12 08:05U:APDNNews ReleaseApplied DNA Announces 1-For-50 Reverse Stock Split Effective March 14, 2025
2025-02-13 16:05U:APDNNews ReleaseApplied DNA Reports First Quarter Fiscal 2025 Financial Results and Highlights Operational Progress
2025-02-12 12:02U:APDNNews ReleaseApplied DNA to Report First Quarter Fiscal 2025 Financial Results After Market Close on Thursday, February 13, 2025
2025-02-11 08:33U:APDNNews ReleaseApplied DNA Reminds Shareholders to Vote Ahead of Special Meeting on February 14
2025-01-10 09:02U:APDNNews ReleaseApplied DNA Completes Buildout of GMP Facility for LineaDNA IVT Templates
2025-01-08 16:31U:APDNNews ReleaseApplied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy Carter
2024-12-18 09:02U:APDNNews ReleaseApplied DNA Customer UHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced from Linea DNA
2024-12-17 16:06U:APDNNews ReleaseApplied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines
2024-12-16 10:01U:APDNNews ReleaseApplied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide with Update on GMP Manufacturing Facility Build-out
2024-10-30 07:16U:APDNNews ReleaseApplied DNA Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private Placement
2024-10-15 10:33U:APDNNews ReleaseApplied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16
2024-09-18 10:20U:APDNNews ReleaseApplied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement
2024-09-17 11:51U:APDNNews ReleaseApplied DNA Receives Linea DNA Follow-on Order from Global Manufacturer of IVDs for Cancer Diagnostic Application
2024-09-17 09:17U:APDNNews ReleaseApplied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 3rd Annual mRNA Process Development & Manufacturing Summit
2024-09-11 09:10U:APDNNews ReleaseApplied DNA Launches Mpox Clade I and Clade II Testing Service
2024-09-04 09:11U:APDNNews ReleaseApplied DNA Selected by LRQA for Isotopic Testing Pilot Project in Pakistan